September 19th, 2018
•Here, we present a protocol for antibody arrays to identify alterations in signaling pathways in various cellular models. These changes, caused by drugs/hypoxia/ultra-violet light/radiation, or by overexpression/downregulation/knockouts, are important for various disease models and can indicate whether a therapy will be effective or can identify mechanisms of drugs resistance.
Tags
Related Videos
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved